Oral Delivery of Kidney Targeting Nanotherapeutics for Polycystic Kidney Disease
Yi Huang(University of Southern California), Eun Ji Chung(University of Southern California)
Cited by 2
Related Papers
Enhancing TFEB‐Mediated Cellular Degradation Pathways by the mTORC1 Inhibitor Quercetin
|Oxidative Medicine and Cellular Longevity|2018|29
Oral delivery of nanomedicine for genetic kidney disease
|PNAS Nexus|2024|9